Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
History
Founded in 2005, Cyan has since become a global leader in the pharmaceutical industry. Cyan's products and services have been instrumental in saving and improving the lives of millions of people around the world.
Mission
To deliver high-quality, value-added medicines and services to health care professionals and patients worldwide.
Vision
To be the world leader in providing innovative, high-quality medicines that measurably improve people's health and quality of life.
Key Team
Mr. Glenn D. Jensen (VP of Operations)
Mr. Charles J. Hartmann (VP of Sales & Marketing)
Ms. Amy Beth Nordin (VP of HR & Corp. Sec.)
Recognition and Awards
Cyan has been the recipient of a number of awards and recognition, including being named one of the world's top 10 innovative companies by Fortune Magazine in 2020.